The National Institutes of Health (NIH)


Research (R, P, D and U Announcements)


 

Title (Activity Code) Deadline Announcement Number
Research on the Mechanisms and/or Behavioral Outcomes of Multisensory Processing (R01) Feb 5, June 5, Oct 5 PA-15-347
NIDCR Small Research Grants for Oral Health Data Analysis and Statistical Methodology Development (R03) Feb 16,June 16, Oct 16 PAR-15-344
Imaging Diagnostics of Dental Diseases and Conditions (Caries, Periodontal Disease, Cracked Teeth, and Pulp Vitality) (R43/R44) (R41/R42) Oct 5, Feb 5, June 5 (R43/R44) PA-15-335
(R41/R42) PA-15-336
Advanced Development of Informatics Technologies for Cancer Research and Management (U24) November 21, 2016; June 14, 2017; November 20, 2017; June 14, 2018 PAR-15-331
Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01) November 21, 2016; June 14, 2017; November 20, 2017; June 14, 2018 PAR-15-332
Sustained Support for Informatics Resources for Cancer Research and Management (U24) November 21, 2016; June 14, 2017; November 20, 2017; June 14, 2018 PAR-15-333
Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21) November 21, 2016; June 14, 2017; November 20, 2017; June 14, 2018 PAR-15-334
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp) Due dates may vary by awarding IC PA-15-322
Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp) Due dates may vary by awarding IC PA-15-321
Establishing Outcome Measures for Clinical Studies of Oral and Craniofacial Diseases and Conditions(R01) (R21) (R01) PAR-13-379
(R21) PAR-13-380
Imaging and Biomarkers for Early Cancer Detection (U01) December 14, 2016; July 10, 2017; December 11, 2017; July 10, 2018; December 11, 2018 PAR-16-089
Establishing Outcome Measures for Clinical Studies of Oral and Craniofacial Diseases and Conditions (R01)(R21) (R21) July 16, Nov 16, Mar 16 PAR-13-380
AHRQ Conference Grant Program (R13) Aug 1, Nov 1, Feb 1, May 1 PA-13-017
NIH Support for Conferences and Scientific Meetings (Parent R13/U13) Aug 12, Dec 12, Apr 12 PA-13-347
Minor Use Minor Species Development of Drugs- Research Project Grant (R01) August 12, 2016; January 13, 2017; August 11, 2017; January 12, 2018 RFA-FD-15-004
National Cancer Institute Program Project Applications (P01) Sept 25, Jan 25, May 25 PAR-15-023
Improvement of Animal Models for Stem Cell-Based Regenerative Medicine (R01)(R21)(R24) Sept 25, Jan 25, May 25 (R24) PAR-13-252
Resource Related Research Projects for Development of Animal Models and Related Materials (R01)(R21)(R24) Sept 25, Jan 25, May 25 (R24) Jan 25, May 25, Sept 25
Cancer Education Grants Program (R25) Sept 25, Jan 25, May 25 PAR-12-049
Early-life Factors and Cancer Development Later in Life (R01, R03, R21) (R01) Oct 5, Feb 5, June 5 (R01) PA-15-126
Establishing Behavioral and Social Measures for Causal Pathway Research in Dental, Oral and Craniofacial Health (R21)(R01) (R01) Oct 5, Feb 5, June 5 (R01) PAR-14-143
Immune System Plasticity in the Pathogenesis and Treatment of Complex Dental, Oral, and Craniofacial Diseases (R01) Oct 5, Feb 5, June 5 PAR-15-192
NIDCR Clinical Trial or Biomarker Clinical Validation Study Cooperative Agreement (U01) Oct 5, Feb 5, June 5 PAR-15-059
Advancing Interventions to Improve Medication Adherence (R01) Oct 5, Feb 5, June 5 PA-14-334
Unconventional Roles of Ethanol Metabolizing Enzymes, Metabolites, and Cofactors in Health and Disease (R01) Oct 5, Feb 5, June 5 PA-15-058
Healthy Habits: Timing for Developing Sustainable Healthy Behaviors in Children and Adolescents (R01) Oct 5, Feb 5, June 5 PA-14-177
Self-Management for Health in Chronic Conditions (R01) Oct 5, Feb 5, June 5 PA-14-344
Biology of the Temporomandibular Joint in Health and Disease (R01) Oct 5, Feb 5, June 5 PA-14-358
Discovery of in vivo Chemical Probes (R01) Oct 5, Feb 5, June 5 PAR-14-279
Understanding and Promoting Health Literacy (R01) (R03) (R21) (R01) Oct 5, Feb 5, June 5 (R01) PAR-13-130
Mechanisms, Models, Measurement, & Management in Pain Research (R01) (R03) (R21) (R01) Oct 5, Feb 5, June 5 (R01) PA-13-118
Research on Ethical Issues in Biomedical, Social, and Behavioral Research (R01) (R03) (R21) (R01) Oct 5, Feb 5, June 5 (R01) PA-11-180
Identifying Non-coding RNA Targets for Early Detection of Cancer (R01) (R21) (R01) Oct 5, Feb 5, June 5 (R01) PA-12-213
Early Stage Development of Technologies in Biomedical Computing, Informatics, and Big Data Science (R01) Oct 5, Feb 5, June 5 PA-14-155
Establishing Outcome Measures for Clinical Studies of Oral and Craniofacial Diseases and Conditions (R01)(R21) (R01) Oct 5, Feb 5, June 5 (R01) PAR-13-379
Nutrition and Alcohol-Related Health Outcomes (R01, R03, R21) (R01) Oct 5, Feb 5, June 5 (R01) PA-13-359
Research on the Health of LGBTI Populations (R01, R03, R21) (R01) Oct 5, Feb 5, June 5 (R01) PA-12-111
Biomarkers for Early Detection of Hematopoietic Malignancies (R01) (R21) (R01) Oct 5, Feb 5, June 5 (R01) PA-12-221
Improvement of Animal Models for Stem Cell-Based Regenerative Medicine (R01)(R21)(R24) (R01) Oct 5, Feb 5, June 5 (R01) PAR-13-114
NIDCR Clinical Trial Implementation or Biomarker Clinical Evaluation Study Cooperative Agreement (U01) Oct 5, Feb 5, June 5 PAR-11-339
Bioengineering Research Grants (BRG) (R01) Oct 5, Feb 5, June 5 PAR-13-137
Systems Science and Health in the Behavioral and Social Sciences (R01) Oct 5, Feb 5, June 5 (R01) PAR-15-048
Dissemination and Implementation Research in Health (R21)(R03)(R01) (R01) Oct 5, Feb 5, June 5 (R01) PAR-13-374
Modeling Social Behavior (R01) Oct 5, Feb 5, June 5 PAR-13-374
Research on Malignancies in the Context of HIV/AIDS (R01) Oct 5, Feb 5, June 5 PA-13-377
Research Project Grant (Parent R01) Oct 5, Feb 5, June 5 PA-13-302
Genetic Susceptibility and Variability of Human Structural Birth Defects (R01) Oct 5, Feb 5, June 5 PA-14-056
Mechanisms of Alcohol-associated Cancers (R01) and Mechanisms of Alcohol-associated Cancers (R21) (R01) Oct 5, Feb 5, June 5 (R01) PA-12-146
Early-life Factors and Cancer Development Later in Life (R03, R21) (R21) (R03) Oct 16, Feb 16, June 16 (R03) PA-15-124
(R21) PA-15-125
Establishing Behavioral and Social Measures for Causal Pathway Research in Dental, Oral and Craniofacial Health (R21)(R01) (R21) Oct 16, Feb 16, June 16 (R21) PAR-14-144
Immune System Plasticity in the Pathogenesis and Treatment of Complex Dental, Oral, and Craniofacial Diseases (R21) Oct 16, Feb 16, June 16 PAR-15-193
Unconventional Roles of Ethanol Metabolizing Enzymes, Metabolites, and Cofactors in Health and Disease (R21) Oct 16, Feb 16, June 16 PA-15-057
NIDCR Clinical Trial or Biomarker Clinical Validation Study Planning Grant (R34) Oct 16, Feb 16, June 16 PAR-14-346
NIDCR Behavioral or Social Intervention Clinical Trial Planning Grant (R34) Oct 16, Feb 16, June 16 PAR-14-342
Healthy Habits: Timing for Developing Sustainable Healthy Behaviors in Children and Adolescents (R21) Oct 16, Feb 16, June 16 PA-14-176
Advancing Interventions to Improve Medication Adherence (R21) Oct 16, Feb 16, June 16 PA-14-335
Biology of the Temporomandibular Joint in Health and Disease (R21) Oct 16, Feb 16, June 16 PA-14-359
Self-Management for Health in Chronic Conditions (R21) Oct 16, Feb 16, June 16 PA-14-343
Understanding and Promoting Health Literacy (R01) (R03) (R21) (R21) Oct 16, Feb 16, June 16 (R21) PAR-13-132
Mechanisms, Models, Measurement, & Management in Pain Research (R01) (R03) (R21) (R03) Oct 16, Feb 16, June 16 
(R21) Oct 16, Feb 16, June 16
(R03) PA-13-117
(R21) PA-13-119
Research on Ethical Issues in Biomedical, Social, and Behavioral Research (R01) (R03) (R21) (R03) Oct 16, Feb 16, June 16
(R21) Oct 16, Feb 16, June 16
(R03) PA-11-181
(R21) PA-11-182
Identifying Non-coding RNA Targets for Early Detection of Cancer (R01) (R21) (R21) Oct 16, Feb 16, June 16 (R21) PA-12-214
Nutrition and Alcohol-Related Health Outcomes (R01, R03, R21) (R03) Oct 16, Feb 16,June 16 
(R21) Oct 16, Feb 16, June 16
(R03) PA-13-360
(R21) PA-13-361
Mechanisms of Alcohol-associated Cancers (R01) and Mechanisms of Alcohol-associated Cancers (R21) (R21) Oct 16, Feb 16, June 16 (R21)PA-12-147
Research on the Health of LGBTI Populations (R01, R03, R21) (R03) Oct 16, Feb 16, June 16 
(R21) Oct 16, Feb 16, June 16
(R03) PA-12-112
(R21) PA-12-113
Biomarkers for Early Detection of Hematopoietic Malignancies (R01) (R21) (R21) Oct 16, Feb 16, June 16 (R21) PA-12-220
Research on Malignancies in the Context of HIV/AIDS (R21) Oct 16, Feb 16, June 16 PA-13-378
Improvement of Animal Models for Stem Cell-Based Regenerative Medicine (R01)(R21)(R24) (R21) Oct 16, Feb 16,  June 16 (R21) PAR-13-115
Systems Science and Health in the Behavioral and Social Sciences (R21) (R21) Oct 16, Feb 16, June 16 (R21) PAR-15-047
Behavioral and Social Science Research on Understanding and Reducing Health Disparities (R01)(R21) (R21) Oct 16, Feb 16, June 16 (R21) PA-13-288
Dissemination and Implementation Research in Health (R21)(R03)(R01) (R03) Oct 16, Feb 16,  June 16
(R21) Oct 16, Feb 16, June 16
(R03) PAR-13-056
(R21) PAR-13-054
Exploratory/Developmental BioengineeringResearch Grants (EBRG) [R21] Oct 16, Feb 16, June 16 PA-12-284
NIDCR Small Grant Program for New Investigators (R03) Oct 16, Feb 16, June 16 PAR-13-348
NIDCR Small Research Grants for Oral Health Data Analysis and Statistical Methodology Development (R03) Oct 16, Feb 16, June 16 PAR-13-044
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21) Oct 16, Feb 16, June 16 PA-12-284
Development of Animal Models and Related Biological Materials for Research (R21) Oct 16, Feb 16, June 16 PA-13-145
NIDCR Small Research Grants for Secondary Analysis of FaceBase Data (R03) Oct 16, Feb 16, June 16 PAR-13-178
NIH Small Research Grant Program (Parent R03) New: Oct 16, Feb 16, June 16
Resubmission/ Revision: Nov 16, Mar 16, July 16
PA-13-304
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21) Oct 16, Feb 16, June 16 PA-12-284
Academic Research Enhancement Award (Parent R15) Oct 25, Feb 25, June 25 PA-13-313
Academic Research Enhancement Award Oct 25, Feb 25, June 25 PA-13-303
Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21) Nov 30, 2015; June 22, 2016; Nov 30, 2016 PAR-15-053
Imaging and Biomarkers for Early Cancer Detection (R01) Dec 11, 2015 PAR-13-189
Detection of Pathogen-Induced Cancer (DPIC)(R01) Dec 11, 2015 PAR-13-190
Interventions for Health Promotion and Disease prevention in Native American Populations (R01) May 12, 2016; May 12, 2017 PA-14-260
NIH Science Education Partnership Award (SEPA) (R25) June 22, 2016 PAR-14-228
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp) Due dates may vary by awarding IC PA-12-149
Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers Due dates may vary by awarding IC PA-12-150

Fellowship (F) Announcements


Title (Activity Code) Deadline Announcement Number
Ruth L. Kirschstein National Research Service Award (NRSA) Short-Term Institutional Research Training Grant (Parent T35) Sept 25, Jan 25, May 25 PA-14-016
Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32) Sept 25, Jan 25, May 25 PA-14-015
Ruth L. Kirschstein National Research Service Awards for Individual Predoctoral MD/PhD and Other Dual Doctoral Degree Fellows (Parent F30) New: Oct 12, Feb 12, June 12
Renewal: Nov 12, Mar 12, July 12
PA-14-150
Ruth L. Kirschstein National Research Service Awards for Individual Predoctoral Fellows (Parent F31) New: Oct 12, Feb 12, June 12
Renewal: Nov 12, Mar 12, July 12
PA-14-147
Ruth L. Kirschstein National Research Service Awards for Individual Predoctoral Fellowships to Promote Diversity in Health-Related Research (Parent F31 – Diversity) New: Oct 12, Feb 12, June 12
Renewal: Nov 12, Mar 12, July 12
PA-14-148
Ruth L. Kirschstein National Research Service Awards (NRSA) for Individual Postdoctoral Fellows (Parent F32) New: Oct 12, Feb 12, June 12
Renewal: Nov 12, Mar 12, July 12
PA-14-149
Ruth L. Kirschstein National Research Service Awards (NRSA) for Individual Senior Fellows (Parent F33) New: Oct 12, Feb 12, June 12,
Renewal: Nov 12, Mar 12, July 12
PA-14-151

Career (K) Announcements


Title (Activity Code) Deadline Announcement Number
Mentored Patient-Oriented Research Career Development Award to Promote Diversity (K23) Oct 12, Feb 12, June 12 PAR-15-062
NCI Transition Career Development Award to Promote Diversity (K22) Oct 12, Feb 12, June 12 PAR-15-063
Mentored Research Scientist Development Award to Promote Diversity (K01) Oct 12, Feb 12, June 12 PAR-15-064
NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08) Oct 12, Feb 12, June 12 PAR-15-060
The NCI Transition Career Development Award (K22) Oct 12, Feb 12, June 12 PAR-15-056
Cancer Prevention, Control, Behavioral Sciences, and Population Sciences Career Development Award (K07) Oct 12, Feb 12, June 12 PAR-15-033
Investigator Award in Patient-Oriented Research (Parent K24) Oct 12, Feb 12, June 12 PA-14-047
Short-term Mentored Career Enhancement Award in Dental, Oral and Craniofacial Research for Mid-Career and Senior Investigators (K18) Oct 12, Feb 12, June 12 PAR-14-039
Independent Scientist Award (Parent K02) Oct 12, Feb 12, June 12 PA-14-045
Mentored Clinical Scientist Research Career Development Award (Parent K08) Oct 12, Feb 12, June 12 PA-14-046
Mentored Patient-Oriented Research Career Development Award (Parent K23) Oct 12, Feb 12, June 12 PA-14-049
Mentored Quantitative Research Development Award (Parent K25) Oct 12, Feb 12, June 12 PA-14-048
NIDCR Dentist-Scientist Pathway to Independence Award (K99/R00) Oct 12, Feb 12, June 12 PAR-14-057

Training (T) Announcements


Title (Activity Code) Deadline Announcement Number

 Loan Repayment Program (LRP) Announcements


Title (Activity Code) Deadline Announcement Number
Extramural Loan Repayment Program for Clinical Researchers (LRP-CR) November 15, 2016 NOT-OD-16-116
Extramural Loan Repayment Program for Pediatric Research (LRP-PR) November 15, 2016 NOT-OD-16-117
Extramural Clinical Research Loan Repayment Program for Individuals from Disadvantaged Backgrounds (LRP-IDB) November 15, 2016 NOT-OD-16-119
Extramural Loan Repayment Program for Health Disparities Research (LRP-HDR) November 15, 2016 NOT-OD-16-118

Research (R) Announcements


Title: Feasibility Studies to Build Collaborative Partnerships in Cancer Research (P20)
Announcement Number: PAR-16-084
Deadline: January 27, 2017; January 29, 2018, by 5:00 PM local time of applicant organization.
Purpose: Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) invites P20 planning grant applications for developing collaborative partnership between institutions serving underserved health disparity populations and underrepresented students (ISUPS) and NCI- designated Cancer Centers (or Cancer Centers with highly integrated cancer research programs). This FOA is designed to facilitate the planning and execution of focused collaborations in cancer-related research, research experience, and research education. A major goal of the NCI P20 partnership programs is to provide support for investigators at ISUPS and Cancer Centers to conduct cancer research pilot projects and cancer research education program. The purpose of the pilot projects and education program is to allow awardees to obtain preliminary data that will lead to competitive grant applications for funding by the NIH/NCI and/or other Federal/Non-Federal agencies.
Award: The partner applications, ISUPS and Cancer Center, may request $275,000 in direct costs. The combined budget of direct costs cannot exceed $275,000. Applicants may apply for up to 4 years of support.
Eligibility & Guidelines: Here
Announcement Expires: January 30, 2018

Title: Imaging and Biomarkers for Early Detection of Aggressive Cancer (U01)
Announcement Number: PAR-16-089
Deadline: December 14, 2016; July 10, 2017; December 11, 2017; July 10, 2018; December 11, 2018, by 5:00 PM local time of applicant organization.
Purpose: The purpose of this Funding Opportunity Announcement (FOA) is to: (i) invite researchers to submit collaborative research project (U01) applications to improve cancer screening, early detection of aggressive cancer, assessment of cancer risk and cancer diagnosis aimed at integrating multi-modality imaging strategies and multiplexed biomarker methodologies into a singular complementary approach, and (ii) establish a Consortium for Imaging and Biomarkers (CIB) to perform collaborative studies, exchange information, share knowledge and leverage common resources. The research will be conducted by individual multi-disciplinary research teams, hereafter called Units. All Units are expected to participate in collaborative activities with other Units within the Consortium.
Award: The scope of the proposed project should determine the project period. The maximum project period is five years.
Eligibility & Guidelines: Link
Announcement Expires:  December 12, 2016

Title: Research on the Mechanisms and/or Behavioral Outcomes of Multisensory Processing (R01)

Announcement Number: PA-15-347

Deadline: February 5, June 5, October 5 Standard dates apply, by 5:00 PM local time of applicant organization

Purpose: The purpose of this Funding Opportunity Announcement (FOA) is to invite applications that elucidate the mechanisms and/or behavioral outcomes of multisensory processing, the integration or processing of at least two distinct types of sensory input as defined by distinct receptor-type transduction, neural pathways and cognate perceptual quality.  Specifically, multiple sensory inputs may include the major traditional modalities of hearing, vision, taste, smell, balance, and touch.  Additional submodalities of body senses include but are not restricted to thermosensation, body position and proprioception, pain, itch, and general visceral sensation.  This FOA encourages research grant applications investigating multisensory processing in perception or other behavioral and social outcomes and/or the mechanisms underlying multisensory processing in the context of the described specific areas of research interests from the participating NIH Institutes, Centers, and Offices (ICOs).  The FOA is intended to encourage basic, behavioral, and/or clinical research projects examining the interactions between other neural systems, such as cognitive, affective, or motor processes, and multiple sensory modalities.

Award: Application budgets are not limited but need to reflect the actual needs of the proposed project. The scope of the proposed project should determine the project period.  The maximum project period is 5 years.

Eligibility & Guidelines: Here

Announcement Expires:  January 8, 2019


Title: NIDCR Small Research Grants for Oral Health Data Analysis and Statistical Methodology Development (R03)

Announcement Number: PAR-15-344

Deadline: by 5:00 PM local time of applicant organization

Purpose: The goal of this funding opportunity announcement is to support meritorious research projects that involve secondary data analyses of existing oral or craniofacial database resources, or to develop needed statistical methodology for analyzing oral and craniofacial data using existing oral or craniofacial databases. The R03 grant mechanism supports research limited in time and amount for studies in categorical program areas.

Award: A budget for direct costs of up to $100,000 per year, with a maximum of $200,000 over two years, may be requested. The total project period for an application submitted in response to this funding opportunity may not exceed two years.

Eligibility & Guidelines: Here

Announcement Expires: September 8, 2018


 

Title: Imaging Diagnostics of Dental Diseases and Conditions (Caries, Periodontal Disease, Cracked Teeth, and Pulp Vitality) (R43/R44) (R41/R42)
Announcement Number: (R43/R44) PA-15-335
(R41/R42) PA-15-336
Deadline: Standard dates apply, by 5:00 PM local time of applicant organization. October 5, February 5, June 5
Purpose: The intent of this SBIR initiative reissue is to accelerate the advanced development and clinical implementation of reliable, reproducible, highly specific and sensitive imaging diagnostic devices for dental caries, periodontal disease, cracked teeth, and pulp vitality. These new devices must demonstrate superior specificity and sensitivity compared with current diagnostic methods, such as the visual/tactile/radiographic examination for detection of caries, while not increasing health risks for patients. Approaches that could be explored include, but are not limited to: optical coherence tomography (OCT) with or without Raman spectroscopy, MRI image analysis, electrical conductivity measurement (ECM), quantitative laser fluorescence (QLF), alternating current impedance spectroscopy, multi-photon imaging, infrared thermography, infrared fluorescence (IR), ultrasound, and terahertz imaging.  The development of novel modalities is also encouraged.
Award: According to statutory guidelines, total funding support (direct costs, indirect costs, fee) normally may not exceed $150,000 for Phase I awards and $1,000,000 for Phase II awards.  With appropriate justification from the applicant, Congress will allow awards to exceed these amounts by up to 50% ($225,000 for Phase I and $1,500,000 for Phase II). As written in the statute and under appropriate circumstances, NIH can apply for a waiver from SBA to issue an award exceeding $225,000 for Phase I or $1,500,000 for Phase II, if this cap will interfere with NIH‘s ability to meet its mission. Award waivers from the SBA are not guaranteed and may delay the release of funds. Applicants are strongly encouraged to contact NIH program officials prior to submitting any application in excess of the guidelines. In all cases, applicants should propose a budget that is reasonable and appropriate for completion of the research project.
Eligibility & Guidelines: (R43/R44) (R41/R42)Announcement Expires:  September 8, 2018


 

Title: Advanced Development of Informatics Technologies for Cancer Research and Management (U24)
Announcement Number: PAR-15-331
Deadline: November 21, 2016; June 14, 2017; November 20, 2017; June 14, 2018, by 5:00 PM local time of applicant organization.
Purpose: The purpose of this Funding Opportunity Announcement (FOA) is to invite Cooperative Agreement (U24) applications for advanced development and enhancement of emerging informatics technologies to improve the acquisition, management, analysis, and dissemination of data and knowledge across the cancer research continuum, including cancer biology, cancer treatment and diagnosis, cancer prevention, cancer control and epidemiology, and/or cancer health disparities. As a component of the NCI’s Informatics Technology for Cancer Research (ITCR) Initiative, this FOA focuses on emerging informatics technology, defined as one that has passed the initial prototyping and pilot development stage, has demonstrated potential to have a significant and broader impact, has compelling reasons for further improvement and enhancement, and has not been widely adopted in the cancer research field. The central mission of ITCR is to promote research-driven informatics technology across the development lifecycle to address priority needs in cancer research. In order to be successful, proposed development plans must have a clear rationale on why the proposed technology is needed and how it will benefit the cancer research field. In addition, mechanisms to solicit feedback from users and collaborators throughout the development process should be included.
Award: The amount of requested budget may not exceed $600,000 Direct Costs (excluding consortium F&A costs) per year. Letter of Intent is due 30 days before the application due date.
Eligibility & Guidelines: Link
Announcement Expires: June 15, 2018


 

Title: Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01)
Announcement Number: PAR-15-332
Deadline: November 21, 2016; June 14, 2017; November 20, 2017; June 14, 2018, by 5:00 PM local time of applicant organization.
Purpose: The purpose of this Funding Opportunity Announcement (FOA) is to invite Cooperative Agreement (U01) applications for the development of enabling informatics technologies to improve the acquisition, management, analysis, and dissemination of data and knowledge across the cancer research continuum including cancer biology, cancer treatment and diagnosis, cancer prevention, cancer control and epidemiology, and/or cancer health disparities. As a component of the NCI’s Informatics Technology for Cancer Research (ITCR) Program, this FOA focuses on early-stage development from prototyping to hardening and adaptation. Early-stage development is defined for the purpose of this FOA as the initial development or the significant modification of existing tools for new applications. The central mission of ITCR is to promote research-driven informatics technology across the development lifecycle to address priority needs in cancer research. In order to be successful, proposed development plans must have a clear rationale on why the proposed technology is needed and how it will benefit the cancer research field. In addition, mechanisms to solicit feedback from users and collaborators throughout the development process should be included.
Award: Budgets are limited to $300,000 Direct Costs (excluding consortium F&A costs) per year. Letter of Intent is due 30 days before the application due date.
Eligibility & Guidelines:  Link
Announcement Expires: June 15, 2018


 

Title: Sustained Support for Informatics Resources for Cancer Research and Management (U24)
Announcement Number: PAR-15-333
Deadline: November 21, 2016; June 14, 2017; November 20, 2017; June 14, 2018, by 5:00 PM local time of applicant organization.
Purpose: The purpose of this Funding Opportunity Announcement (FOA) is to invite Cooperative Agreement (U24) applications for the continued development and sustainment of high-value informatics research resources to serve current and emerging needs across the cancer research continuum including cancer biology, cancer treatment and diagnosis, cancer prevention, cancer control and epidemiology, and/or cancer health disparities. As a component of the NCI’s Informatics Technology for Cancer Research (ITCR) Program, this FOA focuses on supporting activities necessary for improved user experience and availability of existing, widely-adopted informatics tools and resources.  This is in contrast to early-stage and advanced development efforts to generate these tools and resources that are supported by companion ITCR FOAs. The central mission of ITCR is to promote research-driven informatics technology across the development lifecycle to address priority needs in cancer research. In order to be successful, the proposed sustainment plan must provide clear justifications for why the research resource should be maintained and how it has benefited and will continue to benefit the cancer research field.  In addition, mechanisms for assessing and maximizing the value of the resource to researchers and supporting collaboration and/or deep engagement between the resource and the targeted research community should be described.
Award: Application budgets are not limited but need to reflect the actual needs of the proposed project.  The maximum project period is five years. Letter of Intent is due 30 days before the application due date.
Eligibility & Guidelines:  Link
Announcement Expires: June 15, 2018


 

Title: Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21)
Announcement Number: PAR-15-334
Deadline: November 21, 2016; June 14, 2017; November 20, 2017; June 14, 2018, by 5:00 PM local time of applicant organization.
Purpose: The purpose of this Funding Opportunity Announcement (FOA) is to invite exploratory/developmental research grant (R21) applications for the development of innovative methods and algorithms in biomedical computing, informatics, and data science addressing priority needs across the cancer research continuum, including cancer biology, cancer treatment and diagnosis, cancer prevention, cancer control and epidemiology, and/or cancer health disparities.  As a component of the NCI’s Informatics Technology for Cancer Research (ITCR) Initiative, this FOA encourages applications focused on the development of novel computational, mathematical, and statistical algorithms and methods that can considerably improve acquisition, management, analysis, and dissemination of relevant data and/or knowledge. The central mission of ITCR is to promote research-driven informatics technology across the development lifecycle to address priority needs in cancer research. In order to be successful, the proposed informatics method or algorithm must have a clear rationale on why it is novel and how it will benefit the cancer research field. Potential applicants who are interested in more downstream tool development, from prototyping to hardening and adaptation, should consult the other companion FOAs listed above.
Award: Direct costs are limited to $275,000 over a two year period. No more than $200,000 may be requested in any single year. The maximum project period is two years.
Eligibility & Guidelines: Link
Announcement Expires: June 15, 2018

Title: Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp)
Announcement Number: PA-15-321
Deadline: Due dates may vary by awarding IC. See Table of IC-Specific Information, Requirements and Staff Contacts for more details.
Purpose: The Office of Research on Women’s Health (ORWH) and participating Institutes and Centers (ICs) of the National Institutes of Health (NIH) announce the continuation of the program for administrative supplements to research grants to support individuals with high potential to re-enter an active research career after an interruption for family responsibilities or other qualifying circumstances. The purpose of these supplements is to encourage such individuals to re-enter research careers within the missions of all the program areas of NIH. This program will provide administrative supplements to existing NIH research grants for the purpose of supporting full-time or part-time research by these individuals to update their existing research skills and knowledge.
Award: Individual(s) must hold an active grant or cooperative agreement, and the research proposed in the supplement must be accomplished within the competitive segment of the active award. Individuals are encouraged to work with their organizations to develop applications for support. The requested salary and fringe benefits for a re-entry candidate must be in accordance with the salary structure of the grantee institution, consistent with the level of effort. An additional amount up to $10,000 may be requested for supplies, domestic travel, and publication costs relevant to the proposed research. Equipment may not be purchased as a part of this supplement without justification and specific prior approval of the NIH awarding component.The funding mechanism being used to support this program, administrative supplements, can be used to cover cost increases that are associated with achieving certain new research objectives, as long as the research objectives are within the original scope of the peer reviewed and approved project, or the cost increases are for unanticipated expenses within the original scope of the project. Any cost increases need to result from making modifications to the project that would increase or preserve the overall impact of the project consistent with its originally approved objectives and purposes.
Eligibility & Guidelines: Link
Announcement Expires: September 30, 2018

Title: Research Supplements to Promote Diversity in Health-Related Research (Admin Supp)
Announcement Number: PA-15-322
Deadline: Due dates may vary by awarding IC.  See Table of IC-Specific Information, Requirements and Staff Contacts for more details.
Purpose: The National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC) hereby notify Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) holding specific types of research grants (activity codes listed above) that funds are available for administrative supplements to improve the diversity of the research workforce by recruiting and supporting students, postdoctorates, and eligible investigators from groups that have been shown to be underrepresented in health-related research. This supplement opportunity is also available to PD(s)/PI(s) of research grants who are or become disabled and need additional support to accommodate their disability in order to continue to work on the research project.  Administrative supplements must support work within the scope of the original project.
Award: Application budgets are limited to no more than the amount of the current parent award, and must reflect the actual needs of the proposed project. Direct costs for individual administrative supplements vary from less than $5,000 to more than $100,000 depending on the career level of the candidate. Administrative supplements end with the competitive cycle of the parent grant. Budget requests may also be limited by the awarding IC.  See Table of IC-Specific Information, Requirements and Staff Contacts for more details.The funding mechanism being used to support this program, administrative supplements, can be used to cover cost increases that are associated with achieving certain new research objectives, as long as the research objectives are within the original scope of the peer reviewed and approved project, or the cost increases are for unanticipated expenses within the original scope of the project. Any cost increases need to result from making modifications to the project that would increase or preserve the overall impact of the project consistent with its originally approved objectives and purposes.The project and budget periods must be within the currently approved project period for the existing parent award.Eligibility & Guidelines: Link
Announcement Expires: September 30, 2018


Title: Establishing Behavioral and Social Measures for Causal Pathway Research in Dental, Oral and Craniofacial Health (R01) (R21)
Announcement Number: (R01) PAR-14-143(R21) PAR-14-144
Deadline: (R21) Standard dates apply:
New: February 16, June 16, October 16
Resubmission, Revision: March 16, July 16, November 16
(R01) Standard dates apply:
New: February 5, June 5, October 5
Resubmission, Revision: March 5, July 5, November 5
Purpose: The purpose of this funding opportunity announcement is to encourage the establishment of psychometrically-sound measures of specific behavioral or social phenomena that can be used to test causal hypotheses about behavioral and social contributors to dental, oral or craniofacial diseases. Measures can be developed de novo, or adapted from existing measures, e.g., those used in other fields or for different purposes. In either case, applications should include appropriate psychometric tests of the measure(s), and testing for acceptability of use with the target population. This announcement calls for the development of two types of measures: 1) measures of the health behaviors, social interactions, community characteristics, built environments, etc., targeted by behavioral or social interventions to improve oral health; and 2) measures of the hypothesized moderators and mediators of a behavioral or social intervention’s effect.
Award: (R21) The combined budget for direct costs for the two year project period may not exceed $275,000. No more than $200,000 may be requested in any single year. Applicants may request direct costs in $25,000 modules, up to the total direct costs limitation of $275,000 for the combined two-year award period. The total project period for an application submitted in response to this funding opportunity announcement may not exceed 2 years. (R01) The total project period for an application submitted in response to this funding opportunity announcement may not exceed 5 years. Application budgets are not limited but need to reflect the actual needs of the proposed project.
Eligibility and Guidelines:
(R21)->Link
(R01)
Announcement Expires: May 8, 2017


Title: Self-Management for Health in Chronic Conditions (R15)
Announcement Number: PA-14-345
Deadline: February 25, June 25, October 25 Standard dates apply, by 5:00 PM local time of applicant organization.
Purpose: The purpose of this initiative is to support research in self-management focused across conditions. A recent report from the Institute of Medicine (IOM) identifies the epidemic of chronic condition as the nation’s leading health challenge and calls for cross-cutting, coordinated public health actions for “living well with chronic illness”. This Funding Opportunity Announcement (FOA) addresses that recommendation by describing an initiative that focuses on self-management as a mainstream science in order to reduce the burden of chronic illnesses/conditions. Self-management is the ability of the individual, in conjunction with family, community, and healthcare professionals, to manage symptoms, treatments, lifestyle changes, and psychosocial, cultural, and spiritual consequences associated with a chronic illness or condition.
Award: Applicants may request up to $300,000 in direct costs plus applicable Facilities & Administrative (F&A)/indirect costs for the entire project period of up to 3 years. Note when a consortium is involved, the $300,000 direct cost limit is exclusive of consortium F&A costs. These can be requested in addition to the $300,000 direct costs limit. The maximum project period is 3 years.
Eligibility & Guidelines: Link
Announcement Expires: January 8, 2018


Title: Biology of the Temporomandibular Joint in Health and Disease (R21)
Announcement Number: PA-14-359
Deadline: October 16, February 16, June 16 Standard dates apply, by 5:00 PM local time of applicant organization.
Purpose: The purpose of this FOA is to encourage research that will advance our understanding of the temporomandibular joint (TMJ) in health and disease and to stimulate research that complements previous efforts and focuses on the biology of joint function and the tissues that make up the TMJ. A better understanding of total joint structure and mechanics including the interactions of the skeletal, muscular, nervous, immune, and circulatory systems using new in vivo and in vitro models is needed. An expected outcome of this FOA is new knowledge that will provide a basis for developing novel approaches to prevent, diagnose, assess risk, and treat temporomandibular joint disorder (TMD)
Award: The combined budget for direct costs for the two year project period may not exceed $275,000. No more than $200,000 may be requested in any single year. Applicants may request direct costs in $25,000 modules, up to the total direct costs limitation of $275,000 for the combined two-year award period.
Eligibility & Guidelines: Link
Announcement Expires: September 8, 2017


Title: Advancing Interventions to Improve Medication Adherence (R21)
Announcement Number: PA-14-335
Deadline: October 16, February 16, June 16
Standard dates apply, by 5:00 PM local time of applicant organization.
Purpose: This funding opportunity announcement (FOA) is being issued by the NIH Adherence Network through the Office of Behavioral and Social Sciences Research (OBSSR), with participation from multiple NIH Institutes. This FOA encourages Exploratory/Developmental Research Project Grant (R21) applications for research and development of interventions to significantly improve medication adherence in individuals. Applications may target medication adherence in the context of treatment for a single illness or chronic condition (e.g., hypertension), to stave off a disease recurrence (e.g., cancer) or for multiple comorbid conditions (e.g., hypertension, diabetes, alcohol use disorders and HIV/AIDS). A well-articulated theoretical or conceptual framework is key for applications encouraged under this announcement. Applicants should demonstrate the feasibility of collecting multi-modal data on the targets of the intervention including: a patient self-report of medication adherence, at least one non-self-report measure of medication adherence (e.g., pharmacy refill records, electronic monitoring, etc.), and a relevant health outcome or biomarker (e.g., blood pressure, viral load in HIV-infected individuals, cholesterol levels, HbA1c) that is expected to be affected by changes in the targeted adherence behavior. For diseases without identified biomarkers, inclusion of a clinical assessment (e.g., a medicine blood level, diagnostic interview or an independent clinician rating of the symptoms and behaviors) may be considered. Applications for R21 awards should describe projects distinct from those supported through the traditional R01 mechanism. The National Cancer Institute (NCI) is interested in basic and applied research in the behavioral, social, and population sciences to create or enhance interventions that reduce cancer risk, incidence, morbidity and mortality, and improve quality of life.
Award: The combined budget for the direct costs for the two-year project period may not exceed $275,000. No more than $200,000 may be requested in any single year.
Eligibility & Guidelines: Link
Announcement Expires: January 8, 2018


Title: Immune System Plasticity in the Pathogenesis and Treatment of Complex Dental, Oral, and Craniofacial Diseases (R01)
Announcement Number: PAR-15-192
Deadline: Standard dates (June 5, October 5, February 5) apply, by 5:00 PM local time of applicant organization.
Purpose: The purpose of this Funding Opportunity Announcement (FOA) is to encourage research projects to elucidate the role of immune system plasticity in health and in the pathogenesis of dental, oral, and craniofacial diseases. The goal is to advance knowledge of the immunological basis of dental, oral, and craniofacial diseases, and to develop tools and technologies for precise modulation of the immune system to restore or maintain health. The expectation is that new knowledge derived from this research will facilitate development of novel immunomodulatory therapies to prevent disease onset or reverse disease progression.
Specific areas of interest as they are applied to DOC diseases and conditions include, but are not limited to:
Identification of genetic loci and environmental factors
• Development of systems biology approaches to understand innate and adaptive immune responses and plasticity within the context of tissue homeostasis in health and disease, identification of key signaling molecules and networks that can serve as effective diagnostic and therapeutic targets, and development of tools and technologies to permit precise manipulation of these targets to restore health.
• Development of new and improvement of existing animal models reflecting the pathogenesis of human inflammatory diseases
• Development of experimental tools and technologies for precise and predictable modulation of immune system plasticity and functions
• Advancement in the understanding of endogenous cellular and molecular mediators that maintain normal tissue homeostasis, prevent inflammatory disease progression, and initiate and control inflammatory responses, immune activation, and microbial translocation in oral infections, including those that control transition from acute to chronic conditions.
• Development of treatment or prevention for DOC diseases based on precise modulation of immune system plasticity and functions, and identification of optimal conditions for fighting infections, pathological immune activation, and aberrant inflammation.
Studies that propose the testing of immune modulators that are already in early or late phases of clinical trials are discouraged unless proposed in the context of studying combination therapies with other novel targeted agents; studies that involve the testing of novel immuno-modulators are strongly encouraged.
Award: Application budgets are not limited but need to reflect the actual needs of the proposed project. The scope of the proposed project should determine the project period. The maximum project period is 5 years.
Eligibility & Guidelines: Link
Announcement Expires: September 8, 2018


Title: Immune System Plasticity in the Pathogenesis and Treatment of Complex Dental, Oral, and Craniofacial Diseases (R21)
Announcement Number: PAR-15-193
Deadline: Standard dates (June 16, October 16, February 16) apply, by 5:00 PM local time of applicant organization.
Purpose: The purpose of this Funding Opportunity Announcement (FOA) is to encourage research projects to elucidate the role of immune system plasticity in health and in the pathogenesis of dental, oral, and craniofacial diseases. The goal is to advance knowledge of the immunological basis of dental, oral, and craniofacial diseases, and to develop tools and technologies for precise modulation of the immune system to restore or maintain health. The expectation is that new knowledge derived from this research will facilitate development of novel immunomodulatory therapies to prevent disease onset or reverse disease progression.
Award: Specific areas of interest as they are applied to DOC diseases and conditions include, but are not limited to:
• Identification of genetic loci and environmental factors, including host genome interactions with the microbiome, that contribute to immune dysfunction and pathological immune system plasticity associated with DOC diseases.
• Development of systems biology approaches to understand innate and adaptive immune responses and plasticity within the context of tissue homeostasis in health and disease, identification of key signaling molecules and networks that can serve as effective diagnostic and therapeutic targets, and development of tools and technologies to permit precise manipulation of these targets to restore health.
• Development of new and improvement of existing animal models reflecting the pathogenesis of human inflammatory diseases.
• Development of experimental tools and technologies for precise and predictable modulation of immune system plasticity and functions
• Advancement in the understanding of endogenous cellular and molecular mediators that maintain normal tissue homeostasis, prevent inflammatory disease progression, and initiate and control inflammatory responses, immune activation, and microbial translocation in oral infections, including those that control transition from acute to chronic conditions.
• Development of treatment or prevention for DOC diseases based on precise modulation of immune system plasticity and functions, and identification of optimal conditions for fighting infections, pathological immune activation, and aberrant inflammation.
Studies that propose the testing of immune modulators that are already in early or late phases of clinical trials are discouraged unless proposed in the context of studying combination therapies with other novel targeted agents; studies that involve the testing of novel immuno-modulators are strongly encouraged.
Award: The combined budget for direct costs for the two year project period may not exceed $275,000. No more than $200,000 may be requested in any single year.
Eligibility & Guidelines: Link
Announcement Expires: September 8, 2018


Title: Advancing Interventions to Improve Medication Adherence (R01)
Announcement Number: PA-14-334
Deadline: (R01)February 5, June 5, October 5 (R21) October 16, February 16, June 16 Standard dates apply, by 5:00 PM local time of applicant organization.
Purpose: This funding opportunity announcement (FOA) is being issued by the NIH Adherence Network through the Office of Behavioral and Social Sciences Research (OBSSR), with participation from multiple NIH Institutes and Centers. This FOA seeks Research Project Grant (R01) applications that propose interventions to significantly improve medication adherence in individuals. Applications may target medication adherence in the context of treatment for a single illness or chronic condition (e.g., hypertension), to stave off a disease recurrence (e.g., cancer) or for multiple comorbid conditions (e.g., hypertension, diabetes, alcohol use disorders and HIV/AIDS). A well-articulated theoretical or conceptual framework is key for applications encouraged under this announcement. Primary outcomes of the research can include a patient self-report of medication adherence, but must also at least one non-self-report measure of medication adherence (e.g., pharmacy refill records, electronic monitoring, etc.). In addition, applications are encouraged to include a relevant health outcome or biomarker (e.g., blood pressure, viral load in HIV-infected individuals, cholesterol levels, HbA1c) that is expected to be affected by changes in the targeted adherence behavior. For diseases without identified biomarkers, inclusion of a clinical assessment (e.g., a medicine blood level, diagnostic interview or an independent clinician rating of the symptoms and behaviors) may be considered
The National Cancer Institute (NCI) is interested in basic and applied research in the behavioral, social, and population sciences to create or enhance interventions that reduce cancer risk, incidence, morbidity and mortality, and improve quality of life.
Award: Application budgets are not limited but need to reflect the actual needs of the proposed project.
Eligibility & Guidelines: Link
Announcement Expires: January 8, 2018


Title: NIDCR Behavioral or Social Intervention Clinical Trial Planning Grant (R34)
Announcement Number: PAR-14-342
Deadline: October 16, February 16, June 16
Purpose: The NIDCR recognizes that behavioral and social factors play a role in many dental, oral and craniofacial (DOC) disorders and conditions, and that behavioral and social interventions have the potential to improve these conditions by targeting key behavioral and social factors. The NIDCR is committed to supporting the development and testing of behavioral and social interventions to improve DOC health, and to supporting careful planning for these intervention studies. The purpose of this FOA is to provide support for planning well-designed, rigorously-conducted behavioral or social intervention studies relevant to DOC health. The R34 grant will support activities that include, but are not limited to: the development of the behavioral or social intervention manual and procedures for training interventionists; development of the clinical protocol that will guide a subsequent clinical trial; the tools for data management, participant safety and operational oversight; and other activities to prepare for a subsequent clinical trial. R34 applications preparing for a behavioral or social intervention study may involve human subjects as part of small-scale testing of the feasibility and acceptability of the intervention(s), measures, methods, training approaches, etc. However, the R34 planning grant is not meant to support efficacy testing of interventions.
Award: Direct costs may not exceed $150,000. The total project period may not exceed one year.
Eligibility & Guidelines: Link
Announcement Expires: September 8, 2017


Title: NIDCR Clinical Trial or Biomarker Clinical Validation Study Planning Grant (R34)
Announcement Number: PAR-14-346
Deadline: October 16, February 16, June 16 apply, by 5:00 PM local time of applicant organization.
Purpose: The NIDCR is committed to identifying effective approaches to address dental, oral and craniofacial diseases and disorders. Improving health through the generation of robust data from well-designed and executed clinical trials and clinical studies is a high priority for the NIDCR. To meet this goal, the NIDCR strongly encourages investigators proposing investigator-initiated interventional clinical trials or biomarker clinical validation studies to utilize a two-part grant process: Part 1: The NIDCR Clinical Trial or Biomarker Clinical Validation Study Planning Grant (R34). The NIDCR will support clinical trial or biomarker clinical validation study planning grants (R34) for comprehensive planning, design and documentation of investigator-initiated Phase I, II, III, or IV clinical trials, or biomarker clinical validation studies that involve prospective collection of specimens and clinical outcomes. Part 2: The NIDCR Clinical Trial or Biomarker Clinical Validation Cooperative Agreement (U01). The NIDCR will accept, peer review, and consider for funding applications for Clinical Trial Implementation or Biomarker Clinical Validation Study Cooperative Agreements (U01) submitted to PAR-11-339. The material in the implementation or validation grant application must be sufficient to demonstrate adequate preparation for launching a study, i.e., that initiation of study staff training, followed by subject recruitment can begin upon award of the cooperative agreement and approval of the study protocol by the oversight committee.
Award: Direct costs may not exceed $150,000. The total project period may not exceed one year.
Eligibility & Guidelines: Link
Announcement Expires: September 8, 2017


Title: Self-Management for Health in Chronic Conditions (R01)
Announcement Number: PA-14-344
Deadline: February 5, June 5, October 5 Standard dates apply, by 5:00 PM local time of applicant organization.
Purpose: The purpose of this initiative is to support research in self-management focused across conditions. A recent report from the Institute of Medicine (IOM) identifies the epidemic of chronic condition as the nation’s leading health challenge and calls for cross-cutting, coordinated public health actions for “living well with chronic illness”. This Funding Opportunity Announcement (FOA) addresses that recommendation by describing an initiative that focuses on self-management as a mainstream science in order to reduce the burden of chronic illnesses/conditions. Self-management is the ability of the individual, in conjunction with family, community, and healthcare professionals, to manage symptoms, treatments, lifestyle changes, and psychosocial, cultural, and spiritual consequences associated with a chronic illness or condition.
Award: The maximum project period is 5 years.
Eligibility & Guidelines: Link
Announcement Expires: January 8, 2018


Title: Biology of the Temporomandibular Joint in Health and Disease (R01)
Announcement Number: PA-14-358
Deadline: February 5, June 5, October 5
Purpose: The purpose of this FOA is to encourage research that will advance our understanding of the temporomandibular joint (TMJ) in health and disease and to stimulate research that complements previous efforts and focuses on the biology of joint function and the tissues that make up the TMJ. A better understanding of total joint structure and mechanics including the interactions of the skeletal, muscular, nervous, immune, and circulatory systems using new in vivo and in vitro models is needed. An expected outcome of this FOA is new knowledge that will provide a basis for developing novel approaches to prevent, diagnose, assess risk, and treat temporomandibular joint disorder (TMD).
Award: Application budgets are not limited but need to reflect the actual needs of the proposed project. The scope of the proposed project should determine the project period.
Eligibility & Guidelines: Link
Announcement Expires: September 8, 2017


Title:Interventions for Health Promotion and Disease prevention in Native American Populations (R01)
Announcement Number: PA-14-260
Deadline: May 12, 2015; May 12, 2016; May 12, 2017, by 5:00 PM local time of applicant organization.
Purpose: The purpose of this funding opportunity announcement (FOA) is to develop, adapt, and test the effectiveness of health promotion and disease prevention interventions in Native American (NA) populations. NA populations are exposed to considerable risk factors that significantly increase their likelihood of chronic disease, substance abuse, mental illness, oral diseases, and HIV-infection. The intervention program should be culturally appropriate and promote the adoption of healthy lifestyles, improve behaviors and social conditions and/or improve environmental conditions related to chronic diseases, the consumption of tobacco, alcohol and other drugs, mental illness, oral disease, or HIV-infection. The intervention program should be designed so that it could be sustained within the entire community within existing resources, and, if successful, disseminated in other Native American communities. The long-term goal of this FOA is to reduce mortality and morbidity in NA communities. For the purposes of this FOA Native Americans include the following populations: Alaska Native, American Indian, and Native Hawaiian. The term ‘Native Hawaiian’ means any individual any of whose ancestors were natives, prior to 1778, of the area which now comprises the State of Hawaii.
Award: The project period is limited to five years. Application budgets are not limited but need to reflect the actual needs of the proposed project.
Eligibility & Guidelines: Link
Announcement Expires: August 25, 2017


Title: NIH Support for Conferences and Scientific Meetings (Parent R13/U13)
Announcement Number: PA-13-347
Deadline: April 12, August 12, December 12
Purpose: The purpose of the NIH Research Conference Grant (R13) and NIH Research Conference Cooperative Agreement (U13) Programs is to support high quality conferences that are relevant to the public health and to the scientific mission of the participating Institutes and Centers.
Award: Most ICs will accept applications for up to 5 years of support when a series of annual or biannual conferences are proposed by a permanently sponsoring organization. Support for conferences held on a less frequent schedule must be applied for individually.
Eligibility and Guidelines: Link
Announcement Expires: September 8, 2016


Title: AHRQ Conference Grant Program (R13)
Announcement Number: PA-13-017
Deadline: February 1, May 1, August 1, and November 1 annually, beginning February 1, 2013
Purpose: The Agency for Healthcare Research and Quality (AHRQ), announces its interest in supporting conferences through the AHRQ Conference Grant Program. AHRQ seeks to support conferences that help to further its mission to improve the quality, safety, efficiency, and effectiveness of health care for all Americans. The types of conferences eligible for support include:
Research development – conferences where issues or challenges in the practice and delivery of health care are defined and a research agenda or strategy for studying them is developed;
Research design and methodology – conferences where methodological and technical issues of major importance in the field of health services research are addressed or new designs and methodologies are developed;
Dissemination and implementation conferences – conferences where research findings and evidence-based information and tools are summarized, communicated and used by organizations and individuals that have the capability to use the information to improve the outcomes, quality, access to, and cost and utilization of health care services; and/or;
Research training, infrastructure and career development – conferences where faculty, trainees and students are brought together with stakeholders to develop, share or disseminate research products, experiences, curricula, syllabi, training competencies. These types of conferences are not for the training of individuals in health services research.
Award: The total costs for a grant awarded under this Funding Opportunity Announcement will not exceed $35,000 annually. Facilities and administrative costs (indirect costs) are not allowed for conference grants.
Guidelines: Link


Title: Improvement of Animal Models for Stem Cell-Based Regenerative Medicine (R01)(R21)(R24)
Announcement Number: (R01)PAR-13-114; (R21)PAR-13-115; (R24)PAR-13-252
Deadline: NIH Standard Dates Apply
(R01)Feb 5, June 5, Oct 5
(R21)Feb 16, June 16, Oct 16
(R24)Jan 25, May 25, Sept 25
Purpose This FOA encourages Research Project Grant applications from institutions and organizations proposing research aimed at characterizing animal stem cells and improving existing, and creating new, animal models for human disease conditions. The intent of this initiative is to facilitate the use of stem cell-based therapies for regenerative medicine. The initiative focuses on the following areas: 1) comparative analysis of animal and human stem cells to provide information for selection of the most predictive and informative model systems; 2) development of new technologies for stem cell characterization and transplantation; and 3) improvement of animal disease models for stem cell-based therapeutic applications.
Award: (R01) (R24) Application budgets are not limited, but need to reflect the actual needs of the proposed project; (R21) The combined budget for direct costs for the two year project period may not exceed $275,000. No more than $200,000 may be requested in any single year. Applicants may request direct costs in $25,000 modules, up to the total direct costs limitation of $275,000 for the combined two-year award period.
Eligibility and Guidelines: (R01) (R21) (R24)
Announcement Expires: (R01)May 8, 2016 (R21)May 8, 2016 (R24)September 8, 2016